Johnson & Johnson (JNJ)
164.09
-0.73
(-0.44%)
USD |
NYSE |
Sep 20, 16:00
164.15
+0.06
(+0.04%)
After-Hours: 20:00
Johnson & Johnson Income from Discontinued Operations (Quarterly)
Income from Discontinued Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Income from Discontinued Operations (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | -- |
March 31, 2024 | -- |
December 31, 2023 | -- |
September 30, 2023 | -- |
Date | Value |
---|---|
June 30, 2023 | -- |
March 31, 2023 | -- |
December 31, 2022 | -- |
September 30, 2022 | -- |
Income from Discontinued Operations Definition
Income from operations that used to be a part of the business but are not any longer. This could be due to the sale of a portion of a business, shutting down a division, or something else.
Income from Discontinued Operations (Quarterly) Range, Past 5 Years
Income from Discontinued Operations (Quarterly) Benchmarks
Amgen Inc | -- |
Eli Lilly and Co | -- |
Merck & Co Inc | -- |
Pfizer Inc | Upgrade |
AbbVie Inc | -- |